Evidence map›Paper›PMID 12628935›Full record

ArticleThe EMBO journal2003

Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9.

Kiyotsugu Yoshida, Hong-Gang Wang, Yoshio Miki, Donald Kufe

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Kiyotsugu YoshidaDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Hong-Gang Wang
Yoshio Miki
Donald Kufe
Harvard University · US

Funding

MOLECULAR MECHANISMS OF ARA-C THERAPY IN MANR01CA029431 · NCI · DANA-FARBER CANCER INSTITUTE · PI KUFE, DONALD W. · 1985 to 2005
$2.0M
Mechanisms of Rad9 Mediated Checkpoints and ApoptosisR01CA090315 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI WANG, HONG-GANG · 2002 to 2006
$1.2M
NCI NIH HHS CA29431NCI NIH HHS CA55241NCI NIH HHS CA90315NCI NIH HHS R01 CA029431NCI NIH HHS R01 CA090315
6 · The paper itself

Abstract

The mammalian homolog of the Schizosaccharomyces pombe Rad9 is involved in checkpoint signaling and the induction of apoptosis. While the mechanisms responsible for the regulation of human Rad9 (hRad9) are not known, hRad9 is subject to hyperphosphorylation in the response of cells to DNA damage. The present results demonstrate that protein kinase Cdelta (PKCdelta) associates with Rad9 and that DNA damage induces this interaction. PKCdelta phosphorylates hRad9 in vitro and in cells exposed to genotoxic agents. The functional significance of the interaction between hRad9 and PKCdelta is supported by the finding that activation of PKCdelta is necessary for formation of the Rad9-Hus1-Rad1 complex. We also show that PKCdelta is required for binding of hRad9 to Bcl-2. In concert with these results, inhibition of PKCdelta attenuates Rad9-mediated apoptosis. These findings demonstrate that PKCdelta is responsible for the regulation of Rad9 in the Hus1-Rad1 complex and in the apoptotic response to DNA damage.

Indexed as

DNA DamageApoptosisAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell DeathCell LineCytarabineDNA-Binding ProteinsEnzyme ActivationGreen Fluorescent ProteinsHumansLuminescent ProteinsPhosphorylationProtein BindingProtein Kinase CProtein Kinase C-deltaAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsCytarabineDNA-Binding ProteinsGreen Fluorescent ProteinsLuminescent ProteinsPRKCD protein, humanProtein Kinase CProtein Kinase C-deltaProtein Serine-Threonine KinasesProto-Oncogene Proteins c-bcl-2rad9 proteinRecombinant ProteinsRNA, Small InterferingTumor Suppressor Proteins

Identifiers

PMID12628935
PMCPMC151076
OpenAlexW2071198627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.